Word

UFAVE

Status

Dead

Status Code

710

Status Date

Friday, September 20, 2024

Serial Number

87562408

Registration Number

5417689

Registration Date

Tuesday, March 6, 2018

Mark Type

4

Filing Date

Wednesday, August 9, 2017

Published for Opposition

Tuesday, December 19, 2017

Cancellation Date

Friday, September 20, 2024

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

The wording "UFAVE" has no meaning in a foreign language.

Trademark Events

Aug 12, 2017

New Application Entered

Aug 15, 2017

New Application Office Supplied Data Entered

Nov 2, 2017

Assigned To Examiner

Nov 9, 2017

Approved For Pub - Principal Register

Nov 29, 2017

Notification Of Notice Of Publication E-Mailed

Dec 19, 2017

Published For Opposition

Dec 19, 2017

Official Gazette Publication Confirmation E-Mailed

Mar 6, 2018

Registered-Principal Register

Nov 9, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 9, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 9, 2022

Teas Change Of Correspondence Received

Nov 9, 2022

Teas Change Of Owner Address Received

Nov 9, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 6, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Sep 20, 2024

Cancelled Sec. 8 (6-Yr)